<< GE Healthcare launches Venue 40, a portable miniaturized ultrasound system | New book on written and visual communications for clinicians and laboratory researchers >>

China’s Ministry of Commerce approves Pfizer's acquisition of Wyeth

Published on September 30, 2009 at 4:46 AM · No Comments

Pfizer Inc (NYSE:PFE) today announced that China’s Ministry of Commerce has approved the company’s pending acquisition of Wyeth. The Ministry’s decision includes Pfizer’s commitment to divest certain animal health assets in China.

“We are pleased to have achieved another significant milestone with the Ministry’s approval of the pending transaction,” said Jeff Kindler, Chairman and Chief Executive, Pfizer.

The transaction remains subject to regulatory approval in Australia, Canada and the United States. Pfizer expects to obtain these approvals shortly and to close the transaction early in the fourth quarter 2009.

http://www.pfizer.com

04076969-2e3e-4364-9ea6-9d71b0cff758|0|.0

Posted in:

Tags: Pfizer

Pfizer's Toviaz (fesoterodine fumarate) receives FDA approval for the treatment of overactive bladderPfizer Inc has announced that the U.S. Food and Drug Administration (FDA) approved Toviaz (fesoterod...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.